Osaka, Japan

Kaori Umemura

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sawai Pharmaceutical Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kaori Umemura. Retrieved from https://idiyas.com/inventor/kaori-umemura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kaori Umemura: Innovator in Pharmaceutical Preparations

Introduction

Kaori Umemura is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on enhancing the stability and purity of pharmaceutical preparations.

Latest Patents

Kaori Umemura holds a patent for a mirabegron-containing tablet, which includes a method for producing a mirabegron-containing pharmaceutical preparation and a method for producing a mirabegron-containing granulated product. This invention aims to provide a mirabegron-containing tablet that maintains the amorphous form of mirabegron even after long-term storage. Additionally, it ensures that the purity of mirabegron is preserved while preventing the generation of related substances during storage. The pharmaceutical preparation includes mirabegron, hypromellose, and polyvinylpyrrolidone, and may also contain a spray-dried granulated product.

Career Highlights

Kaori Umemura is associated with Sawai Pharmaceutical Co., Ltd., where she continues to innovate in the pharmaceutical sector. Her dedication to research and development has led to advancements in drug formulation techniques.

Collaborations

She has collaborated with notable colleagues, including Toshihiro Yanagi and Kenji Nozawa, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kaori Umemura's work exemplifies the importance of innovation in the pharmaceutical industry. Her contributions not only enhance drug stability but also ensure patient safety and efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…